PSTI - 1.26 Inching up in pre-market. Pluristem Advances its Multinational Phase III Critical Limb Ischemia Study, Targeting Initiation at 40 Active Sites by the End of 2017 http://stockcharts.com/c-sc/sc?s=PSTI&p=D&b=5&g=0&i=t81733750206&r=1499691319889 http://stockcharts.com/c-sc/sc?s=PSTI&p=W&b=5&g=0&i=t71998630269&r=1499691300359